help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-0365
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
146/11/4951    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yeung, H. Y.
Right arrow Articles by Wong, C. K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeung, H. Y.
Right arrow Articles by Wong, C. K. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DESFERRIOXAMINE
Medline Plus Health Information
*Ovarian Cancer
Endocrinology Vol. 146, No. 11 4951-4960
Copyright © 2005 by The Endocrine Society

Hypoxia-Inducible Factor-1-Mediated Activation of Stanniocalcin-1 in Human Cancer Cells

Ho Y. Yeung, Keng P. Lai, Hoi Y. Chan, Nai K. Mak, Graham F. Wagner and Chris K. C. Wong

Department of Biology (H.Y.Y., K.P.L., H.Y.C., N.K.M., C.K.C.W.), Hong Kong Baptist University, Kowloon Tong, Hong Kong; and Departments of Physiology and Pharmacology (G.F.W.), The University of Western Ontario, London, Ontario, Canada N6A 5B8

Address all correspondence and requests for reprints to: Dr. Chris K. C. Wong, Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong.

Stanniocalcin-1 (STC1) is an endocrine hormone originally discovered in the corpuscles of Stannius, endocrine glands on kidneys of bony fishes, and also has been identified in mammals. The mammalian STC1 gene is widely expressed in various tissues and appears to be involved in diverse biological processes. There is growing evidence to suggest that altered patterns of gene expression have a role in human cancer development. Recently STC1 has been identified as a stimulator of mitochondrial respiration and has been hypothesized to be functionally related to the Warburg effect, of which hypoxia-inducible factor (HIF)-1 plays a key role in reprogramming tumor metabolism. This prompted us to examine the involvement of HIF-1 in the regulation of STC1 expression in tumor hypoxia. Our data reveal that hypoxia can stimulate STC1 gene expression in various human cancer cell lines, including those derived from colon carcinomas, nasopharyngeal cancer (CNE-2, HONE-1, HK-1), and ovarian cancer (CaOV3, OVCAR3, SKOV3). By far, the greatest response was observed in CNE-2 cells. In further studies on CNE-2 cells, desferrioxamine, cobalt chloride, and O2 depletion all increased HIF-1{alpha} protein and STC1 mRNA levels. Desferrioxamine treatment, when coupled with Fe replenishment, abolished these effects. RNA interference studies further confirmed that endogenous HIF-1{alpha} was a key factor in hypoxia-induced STC1 expression. The ability of vascular endothelial growth factor to stimulate STC1 expression in CNE-2 cells was comparatively low. Collectively, the present findings provide the first evidence of HIF-1 regulation of STC1 expression in human cancer cells. The studies have implications as to the role of STC1 in hypoxia induced adaptive responses in tumor cells.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel
The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth
Endocrinology, May 1, 2008; 149(5): 2403 - 2410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Westberg, M. Serlachius, P. Lankila, and L. C. Andersson
Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1766 - H1771.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. L. Gillespie, K. Whang, B. T. Ragel, J. R. Flynn, D. A. Kelly, and R. L. Jensen
Silencing of Hypoxia Inducible Factor-1{alpha} by RNA Interference Attenuates Human Glioma Cell Growth In vivo
Clin. Cancer Res., April 15, 2007; 13(8): 2441 - 2448.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. A. Westberg, M. Serlachius, P. Lankila, M. Penkowa, J. Hidalgo, and L. C. Andersson
Hypoxic Preconditioning Induces Neuroprotective Stanniocalcin-1 in Brain via IL-6 Signaling
Stroke, March 1, 2007; 38(3): 1025 - 1030.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society